BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 21, 2004
View Archived Issues
Genzyme Beats Estimates With Product Sales, Curbed Expenses
Genzyme Corp. reported third-quarter numbers that beat consensus estimates, and the diversification plans the company put in place over the past year are taking hold, it said. (BioWorld Today)
Read More
Personalized Medicine Coalition Formed To Benefit Health Care
Read More
UN Urged Not To Consider Ban On Stem Cell Research
Read More
BioWorld RNAi Report 2005
Read More
Other News To Note
Read More